Comparison of neoadjuvant and adjuvant chemotherapy for upper tract urothelial carcinoma in real-world practice: a multicenter retrospective studyKazuhiro Takahashi, Takahiro Kimura, Minoru Nakazono et al.|Japanese Journal of Clinical Oncology|2023Cited by 13
The clinical impact of ureteroscopy for upper tract urothelial carcinoma: A multicenter studyJuria Nakano, Fumihiko Urabe, Yuria Kiuchi et al.|International Journal of Urology|2023Cited by 10
Clinical features of medication‐related osteonecrosis of the jaw in prostate cancer managementYuma Goto, Fumihiko Urabe, Juria Nakano et al.|British Journal of Urology|2025Cited by 4
Safety profile of enfortumab vedotin plus pembrolizumab in locally advanced or metastatic urothelial carcinoma: a multicenter Japanese cohort studyKosuke Iwatani, Takahiro Kimura, Fumihiko Urabe et al.|Japanese Journal of Clinical Oncology|2025Cited by 4
Evaluation of optimal timing and therapeutic efficacy of radium-223 therapy for metastatic castration-resistant prostate cancer: a multicenter collaborative studyFumihiko Urabe, Soshi Kadena, Kojiro Tashiro et al.|Japanese Journal of Clinical Oncology|2025Cited by 3